Founded in 1993
  Year: 2005 | Volume: 13 | Issue: 3-4 | Pages: 108-114
  Review Article
Dimitrijevic B
  DOI: 10.2298/AOO0503108D
  Cancer genomics that normally relies on mutational analysis of oncogenes and tumor suppressor genes has approached its inherent limits. This was not much of a surprise having in mind the genome dynamics and the resulting complexity of cancer phenotype and genotype. In response to this challenge, molecular genetics offered a new armory for the analysis of the genetic basis of cancer. This refers to the analysis of molecular features that regulate gene activity and the analysis of products of this activity. In the focus of tuning transcription is the methylation surveillance of the genome of the cell. Modification of proteins associated with chromatin and methylation of CpG sites in DNA was found to affect profoundly gene expression and is commonly termed epigenomics. Quantitative and qualitative characterization of the methylation profile of the cancer cell genome is formidable but necessary task with great potential for molecular pathology of cancer. There is little doubt that this line of research will add a great deal to the clinical practice and the basic science of oncology. The only question is how to make a large database large enough and how select the most reliable and sensitive technological approach with the highest throughput.
  Key words: Neoplasms; Genome, Human
  Read full text in PDF [Full Text]
Next article

Previous article

Table of contents

Browse all Volumes

Search all Volumes
By keywords
By authors

  Search AoO for:

  Related articles in AoO:
About Journal | Editorial Board | Editorial Policy | Instructions for Authors | Open Access | Advertising | Payed issues | Article Submission Charge | Contact
Founder and owner: Oncology Institute of Vojvodina, Serbia
Publisher: Oncology Institute of Vojvodina
Co-publisher: Faculty of Medicine, University of Novi Sad
Online since 1997 (Abstracts only); 2000 (Abstracts and Full text)
ISSN: 0354-7310 eISSN: 1450-9520